
Delays in cancer treatment are 'causing avoidable deaths', Irish Cancer Society warns
Its analysis of new data from the National Cancer Control Programme shows, for the first time, differences between cancer centres.
The target for referrals to Urgent Symptomatic Breast Disease Clinics is to have 95% seen within 10 days. However just 76.3% of referrals hit this between March last year and February this year.
In addition Irish Cancer Society CEO Averil Power warned of regional differences.
In Letterkenny the rate was 59.8% with a low of 5% in December 2024. This compares with Limerick where 97% were seen and 100% in Waterford.
"Research published in the British Medical Journal has found that every four-week delay in starting cancer treatment can increase mortality by 10%. So, there is no question that these delays are causing avoidable deaths," she warned.
Source: Irish Cancer Society.
Source: Irish Cancer Society.
Almost all men diagnosed with prostate cancer at stage one will survive but only half of those diagnosed at stage four.
The data shows variations even within strong-performing sites. Monthly data shows while Cork reached 82.8% of these patients referred to rapid access clinics during all of last year, this dropped to 21.9% in August last year.
Lung cancer is the leading cause of cancer-related deaths in Ireland. In four sites they missed the target by small numbers, and each linked this to capacity issues. One - Waterford – said it was a data issue.
Dr Michael McCarthy, Irish Society of Medical Oncology president and consultant medical oncologist in Galway warned: "I see the human cost of the postcode lottery in Irish cancer care every day.
Once chemotherapy is prescribed, the National Cancer Strategy states that it should start within 15 working days. The reality in Galway is that patients are now typically waiting seven to eight weeks for their first session.
Over 96% of Waterford patients started radiotherapy within target times, delivered in the private UPMC Whitfield hospital.
Funding to upgrade ageing equipment and build more units is vital for Budget 2026, the cancer society urged.
In Tralee, it highlighted a plan to build a dedicated cancer unit that was signed off on in December 2023 but has not started. In Limerick, it called for greater urgency in buying a PET scanner and for Cork more radiology facilities and equipment.
Other feedback indicated shortages of GPs in the community as well as of nurses, radiologists, consultants and radiation therapists in hospitals.
Source: Irish Cancer Society.
When Ziva Cussen, 23, went to her GP in early 2023 with breast cancer concerns, she was referred to a symptomatic breast clinic within five weeks.
Then, however, she said: 'I think I got lost in the system." In July she was given an ultrasound appointment for October.
'I was left waiting seven and a half months for an ultrasound,' she said.
Ziva Cussen, Drogheda, was diagnosed with Stage IV breast cancer aged 21 in 2023. She faced a delay of 7.5 months in getting an ultrasound, and she questions if this impacted her.
'It's a crazy amount of time to be left waiting for a scan that literally could have been done on the day. It's less than 10 minutes, that scan.'
She is now undergoing treatment for advanced breast cancer.
'There's just a lot of delays in the system,' she said. 'And being told 'we're under resourced, and not enough staff' — that's not a good enough reason, I think. People can be left waiting seven and a half months, it's costing people their lives.'
Ms Cussen is a co-founder of 'Too Young to be Heard'. They want the age of public breast screening to be lowered among other age-related reforms.
The data was shared with the Irish Cancer Society through the Regional Health Forum South and Cllr Roger Kennedy.
The HSE National Cancer Control Programme, in response to these concerns, called for certainty around funding to support services.
It highlighted reforms already started, but said: 'To sustain this progress, consistency and assurance around future funding would be helpful.
'The HSE recognises the critical importance of early intervention and the impact that delays can have on patients and their families.'
Cancer survival is improving in Ireland, a spokeswoman added.
'Today, over 220,000 people in Ireland are living with or after cancer, which is a 50% increase compared to a decade ago," she said.
The Cancer Strategy (2017 to 2026) allocated €90m for services development, including hiring the equivalent of 800 full-time workers.
A spokesman for HSE Midwest including UHL said plans for a PET scanner are being developed, 'subject to funding availability in 2025/2026".
The cancer centre has improved access to the Breast Unit with additional waiting list clinics.
An increase in delays last year in accessing systemic therapy was due to a rise in demand, coupled with staffing challenges.
'The recruitment of additional staff has had a positive impact on treatment times. Six consultant oncologists are now in post,' he said.
A new system for all cancer patients means a faster start to treatment, he added.
'Data for May 2025 shows 87% of patients commenced treatment within 15 working days,' he said.
The nine who did not start on time were either too sick or delayed for other personal reasons.
Recruitment is also continuing across HSE Southwest for Cork and Kerry. It shortlisted 18 radiation therapists in June for CUH to fill 11.5 full-time roles.
Read More
Extending bowel cancer screening to over 50s would reduce deaths but cost up to €66m, Hiqa says
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

The Journal
an hour ago
- The Journal
Sharp increase in prescription painkiller use in Ireland
PRESCRIBING OF PAIN medications in Ireland has risen significantly over the past decade, with usage rates now outpacing those in England, new research from RCSI reveals. In Ireland, the use of opioids increased by approximately 25% between 2014 and 2022, while prescriptions for paracetamol rose by 50%. Specific medicines like codeine and stronger opioids increased by even higher percentages. Tapentadol prescriptions rose by 389%, for example. By contrast, England experienced declining use across most classes of pain medications during the same timeframe. The findings are based on a comparison between prescribing data of medical card holders in Ireland – about a third of the population – and all patients at general practices in England. This may contribute to the notable disparity in figures, as older populations are over-represented among medical card holders here. However, it was still found that the Irish and English health systems take markedly different approaches to managing pain issues. Dr Molly Mattsson, who is the First Author of the study and a Postdoctoral Fellow at the RCSI School of Pharmacy and Biomolecular Sciences, said the results show a growing reliance on prescribing pharmacological treatments for pain in Ireland Advertisement 'The trends raise important questions about healthcare access and the availability of non-drug options to manage pain, particularly for medical card holders who avail of public services,' she said. The study says that in England there is 'broad access' to healthcare services including pain clinics and non-pharmacological interventions such as physical therapy through the NHS. These services are less accessible in Ireland, possibly contributing to a greater reliance on medication. In order to reduce the worrying trend, researchers say waiting lists need to be addressed. Orthopaedics currently has the highest number of individuals on outpatient waiting lists, with over 63 000 awaiting an appointment as of March 2024. Some patients with severe degenerative-related chronic pain wait years to be considered for joint replacement surgery, so they need strong analgesics in the meantime, the study says. 'Many of these medications carry risks such as dependency which can be worsened by overprescribing', said Professor Frank Moriarty, a senior author of the study. 'While medication can play an important role in treating pain, we must address issues like orthopaedic surgery waiting times and ensure Irish patients also have access to safe, evidence-based alternatives to medications.' Moriarty added that access to data is equally vital to track how prescribing patterns evolve over time. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal


Irish Independent
18 hours ago
- Irish Independent
Averil Power announced as new chief executive of Clúid Housing
She has been Chief Executive of the Irish Cancer Society since January 2018. She has previously worked as Chief Executive of the Asthma Society and was also a senator and political adviser. Commenting on her appointment, Ms Power said: 'Having grown up in social housing, I know firsthand the lifeline it provides to people who could not afford to rent or buy privately. "I have also seen through my work as a public representative and charity leader the negative impact lack of a secure home is having on the mental and physical health of children and adults across Ireland.' Power worked as a senator from 2011 to 2016 serving on the Industrial and Commercial Panel. Previous to this she worked as a political advisor to Mary Hanafin, but later resigned from the Fianna Fáil party in 2015. 'Clúid is working to change this through its advocacy and by directly delivering record numbers of social, affordable and age friendly homes,' Ms Power added. Current Clúid Chief Executive, Brian O'Gorman, said: 'Under her leadership, the Irish Cancer Society has doubled its income from Daffodil Day and other key campaigns, enabling record growth in the number of people benefiting from its services and research.' 'Averil has a deep personal commitment to equality and social justice, as evident from her previous leadership on issues such as educational disadvantage, marriage equality and the rights of adoptees to know their original identities. 'Her commitment to Clúid's social mission, her vision for inclusive and sustainable growth, and her appreciation for the strength and talent already present across our organisation, underlines my confidence that Clúid is in safe hands as the organisation embarks on its next stage of development,' he said.


Irish Daily Mirror
a day ago
- Irish Daily Mirror
Chikungunya virus symptoms, spread and what to know as 7,000 infected in China
A mosquito-borne virus that has infected more than 7,000 people across 13 cities in southern China is prompting measures similar to those taken during the Covid pandemic - despite not being contagious between humans. The chikungunya virus, which causes fever, joint pain, headaches and muscle aches, is spreading rapidly across Guangdong province, just north of Hong Kong. Chikungunya is typically uncommon in China, but infections soared after an imported case was detected in Foshan city on July 8, which has since become the worst-affected area, reports New York Times. In Foshan city patients diagnosed with chikungunya are required to remain in hospital under mosquito net protection and can only be discharged after testing negative or completing a mandatory week-long stay, according to a translation of Chinese news outlet NF News. Authorities in Guangdong are doing door-to-door inspections checking for stagnant water - where mosquitos breed - and warning that those who fail to comply can be fined or face criminal charges for "obstructing the prevention of infectious diseases", as outlined in a government flyer translated by the Times. A drone sprays insecticide on August 1, 2025 in Guangzhou, Guangdong Province of China (Image: China News Service via Getty Images) Other measures include releasing mosquito-eating fish into ponds, spraying pesticides, deploying drones to spot breeding sites and even introducing giant "elephant mosquitoes" whose larvae devour the virus-carrying kind. While the current outbreak is centred in Asia, Ireland has recorded a travel-related case of the virus in the past. According to the Health Protection Surveillance Centre (HPSC), the most recent known Irish case was in 2016, involving a person who had recently returned from Kenya. Chikungunya is classed as a notifiable disease in Ireland - meaning health officials must report suspected cases to authorities. While it cannot be transmitted person-to-person, the virus can be passed to humans through the bite of an infected Aedes mosquito, which are usually found in the warmer parts of the world, especially Asia, the US and the Mediterranean Basin. What is Chikungunya? The HPSC said: "Chikungunya is a viral infection caused by the Chikungunya virus, an Alphavirus and member of the Togaviridae family. Chikungunya fever is a notifiable disease in Ireland." What are the symptoms ? The HPSC said: "The time between being bitten by an infected mosquito and developing symptoms ranges from 1 to 12 days, with an average of three to seven days. "The main symptoms are fever, joint pain, muscle pain and headache. Joint pains are a characteristic symptom. Bleeding from the nose or gums may happen, particularly in children. "While most cases recover without complications, some people may develop a more chronic phase with persistent joint pains. Recovery may take several weeks for these patients, coinciding with extreme tiredness. Younger people tend to recover in a matter of a one or two weeks while middle-aged and elderly tend to take one to three months for full recovery." How is it spread? The HPSC said: "Chikungunya fever is transmitted to humans by biting Aedes mosquitoes, such as A. aegypti, A. albopictus and A. polynesiensis. These are tropical and subtropical mosquitoes found in the warmer parts of the world, especially Asia, the United States and the Mediterranean Basin. " Where does it occur? The HPSC said: "Chikungunya is commonly found in East Africa, Southeast Asia and in the Indian sub-continent. In summer 2007, an outbreak was reported in the Emilia-Romagna region of North-East Italy, and this region is now considered an area where Chikungunya virus transmission takes place. The most recent cases of Chikungunya in Italy have occurred between June and October 2017 in Rome, the coastal region of Anzio and Latina. "One case of chikungunya was reported in Ireland during 2016, with a recent travel history to Kenya." What do I need to do if I visit an area with Chikungunya? The HPSC said: "Travellers to affected areas are advised to prevent mosquito bites. Pregnant women, immunosuppressed people and people suffering from a severe chronic illness should consult their physicians prior to the travel in order to assess their risk and get recommendations on personal preventive measures. "All travellers to countries where Chikungunya occurs should take the following steps to prevent mosquito bites: Use of anti-mosquito devices (insecticide-treated bed nets, spray, repellents) Mosquito repellent based on a 30% DEET concentration is recommended. Pregnant women and children under the age of 12 years should consult a physician or pharmacist before use. For newborn children under three months, repellents are not recommended and insecticide-treated bed nets and protective clothing should be used instead. Wear long sleeves and trousers." .Subscribe to our newsletter for the latest news from the Irish Mirror direct to your inbox: Sign up here.